Infectious diseases and vaccines Archives - Page 10 of 11

The prevalence of transmitted resistance to first-generation non-nucleoside reverse transcriptase inhibitors and its potential economic impact in HIV-infected patients

Authors: S J Snedecor, A Khachatryan, K Nedrow, R Chambers, C Li, S Haider, J Stephens. Published: PLoS One, 2013 View publication Abstract Non-nucleoside reverse transcriptase inhibitor (NNRTI)-based highly active antiretroviral therapy...

Impact of adverse events on costs and quality of life in protease inhibitor-based combination therapy for hepatitis C

Authors: X Gao, J M Stephens, J A Carter, S Haider, VK Rustgi Published: Expert Review of Pharmacoeconomics Outcomes Research, 2012 View publication Abstract Protease inhibitor with pegylated interferon and ribavirin therapy...

Early-switch/early-discharge opportunities for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections: proof of concept in the United Arab Emirates.

Authors: A El Houfi, N Javed, C T Solem, C Macahilig, J,M Stephens, N Raghubir, R Chambers, J Z Li, S Haider Published: Infection and Drug Resistance, 2015 View publication Objective To...

A cost utility analysis of simeprevir used with peginterferon + ribavirin in the management of genotype 1 hepatitis C virus infection, from the perspective of the UK National Health Service

Authors: K Westerhout, M Treur, A Mehnert, K Pascoe, I Ladha, J Belsey Published: Journal of Medical Economics, 2015 View publication Introduction Triple therapy using a protease inhibitor (PI) with peginterferon and...

Economic analysis of empiric versus diagnostic-driven strategies for immunocompromised patients with suspected fungal infections in the People’s Republic of China

Authors: N Mao, B Lesher, Q Liu, L Qin, Y Chen, X Gao, S R Earnshaw, C L McDade, C Charbonneau Published: ClinicoEconomics and Outcomes Research: CEOR, 2016 View publication Abstract Invasive...

Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus

Authors: W Lawson, D Nathwani, C Eckmann, S Corman, J Stephens, C Solem, C Macahilig, J Li, N Baillon-Plot, C Charbonneau, S Haider Published: Clinical Microbiology and Infection, 2015 View publication Abstract...

Economic evaluation among Chinese patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus and treated with linezolid or vancomycin: a secondary, post-hoc analysis based on a Phase 4 clinical trial study.

Authors: Y Wan, Q Li, Y Chen, S Haider, S Liu, X Gao Published: Journal of Medical Economics, 2016 View publication Objective To assess cost-effectiveness of linezolid vs vancomycin in treating nosocomial...

Nosocomial pneumonia caused by methicillin-resistant staphylococcus aureus treated with linezolid or vancomycin: a secondary economic analysis of resource use from a Spanish perspective

Authors: J Rello; M Nieto; J Solé-Violan; Y Wan; X Gao; CT Solem; M De Salas-Cansado; F Mesa; C Charbonneau; J Chastre Published: Medicina intensiva, 2016 View publication Objectives Adopting a unique...

Burden and treatment patterns of invasive fungal infections in hospitalized patients in the Middle East: real-world data from Saudi Arabia and Lebanon

Authors: A F Alothman, A O Althagafi, M J Matar, R Moghnieh, T H Alenazi, F M Farahat, S Corman, C T Solem, N Raghubir, C Macahilig, C Charbonneau, J M Stephens...

News